patisiran January 19, 2018 patisiran Trade Name Orphan Indication Transthyretin-mediated amyloidosis USA Market Approval USA USA Designation Date 2012-06-07 00:00:00 Sponsor Alnylam Pharmaceuticals, Inc.;300 Third Street;Cambridge, Maryland, 02142
